Literature DB >> 29776702

Naloxone Use Among Emergency Department Patients with Opioid Overdose.

Catherine A Marco1, William Trautman2, Alexander Cook2, Dennis Mann1, Jordan Rasp3, Oswald Perkins2, Michael Ballester1.   

Abstract

BACKGROUND: Emergency department (ED) visits for unintentional opioid overdoses have increased dramatically. Naloxone hydrochloride (Narcan®) is an opioid antagonist commonly used to treat these overdoses.
OBJECTIVE: This study was undertaken to identify experiences regarding naloxone use among ED patients with opioid overdose.
METHODS: This prospective survey study was conducted at an urban level I trauma center. A survey was administered to eligible ED patients after unintentional opioid overdose. This study identified current and previous use of naloxone among ED patients with opioid overdose.
RESULTS: Eight-nine ED patients with accidental overdose of opioids participated (90% participation rate). Most participants reported a history of opioid overdose (n = 62 [70%]). A significant minority stated they have had access to a naloxone kit (n = 28 [31%]). Most participants with a naloxone kit stated that their frequency and dosage of opiate use did not change after access to naloxone (n = 17 [63%]), and a few used opiates more often (n = 1 [4%]) or less often (n = 9 [33%]). There was a significant negative correlation between total dose and age (Spearman ρ -0.27; p = 0.01). There was no association between dose and sex.
CONCLUSIONS: Many patients presenting with opioid overdose have had a history of opioid overdose. Patients with opioid overdose required a highly variable dose of naloxone. Higher doses of naloxone were associated with lower age. Despite widespread availability of naloxone to consumers, a minority of patients in this study reported access to naloxone. Participants who had access to a naloxone kit stated that their frequency and dosage of opioid use did not change.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  naloxone; opioid; opioid overdose

Mesh:

Substances:

Year:  2018        PMID: 29776702     DOI: 10.1016/j.jemermed.2018.04.022

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  6 in total

1.  Understanding Naloxone Uptake from an Emergency Department Distribution Program Using a Low-Energy Bluetooth Real-time Location System.

Authors:  Jeffrey T Lai; Brittany P Chapman; Stephanie P Carreiro; Kavita M Babu; Edward W Boyer; Peter R Chai
Journal:  J Med Toxicol       Date:  2020-04-06

2.  Higher doses of naloxone are needed in the synthetic opiod era.

Authors:  Ronald B Moss; Dennis J Carlo
Journal:  Subst Abuse Treat Prev Policy       Date:  2019-02-18

Review 3.  New and Emerging Opioid Overdose Risk Factors.

Authors:  Ralph Foglia; Anna Kline; Nina A Cooperman
Journal:  Curr Addict Rep       Date:  2021-04-22

4.  Involvement of Opioid System and TRPM8/TRPA1 Channels in the Antinociceptive Effect of Spirulina platensis.

Authors:  Mariana A Freitas; Amanda Vasconcelos; Elaine C D Gonçalves; Eduarda G Ferrarini; Gabriela B Vieira; Donatella Cicia; Maíra Cola; Raffaele Capasso; Rafael C Dutra
Journal:  Biomolecules       Date:  2021-04-17

Review 5.  Treatment of opioid overdose: current approaches and recent advances.

Authors:  Stevie C Britch; Sharon L Walsh
Journal:  Psychopharmacology (Berl)       Date:  2022-04-07       Impact factor: 4.530

6.  "It's my frenemy": A qualitative exploration of knowledge and perceptions of fentanyl use during the COVID-19 pandemic in people who use drugs at a syringe services program in Philadelphia, PA.

Authors:  Sarah Bauerle Bass; Patrick J A Kelly; Sphoorti Pandit-Kerr; Jenine Pilla; Katherine Morris; Erin Larsen; Jennifer P Wisdom; Phillip R Torralva
Journal:  Front Public Health       Date:  2022-07-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.